Jeffrey S. Farrow

Jeffrey S. Farrow is a declared insider at 2 companies (finance chief); the most frequent names are Global Blood Therapeutics, Inc. and Tarsus Pharmaceuticals, Inc. Over a trading history stretching from 1 August 2021 to 17 March 2026, the count stands at 15 filings.

No open-market purchase appears, only 2 sales worth €182k. Besides market trades, the filings include 12 option exercises. Since January 2026: no purchases and 1 sale on the market.

Most recently, on 19 March 2026, the filings show an open-market sale worth €127k in Tarsus Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.